HomeTRDA • NASDAQ
add
Entrada Therapeutics Inc
Previous close
$12.89
Day range
$12.31 - $12.79
Year range
$10.62 - $18.44
Market cap
417.66M USD
Avg Volume
79.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 41.85M | — |
Operating expense | 8.65M | -12.55% |
Net income | -9.54M | 61.25% |
Net profit margin | -22.81 | — |
Earnings per share | -0.28 | 64.10% |
EBITDA | 5.64M | 122.52% |
Effective tax rate | 203.77% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 351.97M | 86.51% |
Total assets | 469.19M | 86.15% |
Total liabilities | 226.83M | 474.23% |
Total equity | 242.36M | — |
Shares outstanding | 32.33M | — |
Price to book | 1.71 | — |
Return on assets | 2.57% | — |
Return on capital | 3.92% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.54M | 61.25% |
Cash from operations | -4.01M | 85.30% |
Cash from investing | 19.04M | 1.34% |
Cash from financing | 690.00K | 92.74% |
Net change in cash | 15.72M | 292.79% |
Free cash flow | 10.43M | 169.44% |
About
Founded
2016
Headquarters
Website
Employees
159